The effects of sevoflurane on serum creatinine and blood urea nitrogen concentrations: A retrospective, twenty-two-center, comparative evaluation of renal function in adult surgical patients

Anesthesia and Analgesia

Volumn 90, Issue 3, 2000, Pages 683-688

  Mazze, Richard I ^a,b,c,f   Callan, Clair M ^c   Galvez, Susan T ^c   Delgado Herrera, Leticia ^c   Mayer, David B ^c,d,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^c ABBOTT LABORATORIES   (United States)

^d UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^e Esurg Incorporated   (United States)

^f Department 97C ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENFLURANE; ISOFLURANE; PROPOFOL; SEVOFLURANE;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE KIDNEY FUNCTION RELATION; FEMALE; HUMAN; INHALATION ANESTHESIA; MAJOR CLINICAL STUDY; MALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NEPHROTOXICITY; PRIORITY JOURNAL; UREA NITROGEN BLOOD LEVEL;

EID: 0034048757     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-200003000-00032     Document Type: Article

References (29)

1. Campbell C, Andreen M, Battito MF, et al. A phase III multi-center open-label randomized comparative study evaluating the effect of sevoflurane versus isoflurane on the maintenance of anesthesia in adult ASA class I, II, and III inpatients. J Clin Anesth 1996;8:557-63.
2. Kharasch ED, Frink EJ Jr, Zagar R, et al. Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity. Anesthesiology 1997;86: 1238-53.
3. Bito H, Ikeuchi Y, Ikeda K. Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia. Anesthesiology 1997;86:1231-7.
4. Conzen PF, Nuscheler M, Melotte A, et al. Renal function and serum fluoride concentrations in patients with stable renal insufficiency after anesthesia with sevoflurane or enflurane. Anesth Analg 1995;81:569-75.
5. Eger EI, Koblin DD, Bowland T, et al. Nephrotoxicity of sevoflurane versus desflurane. Anesth Analg 1997;84:160-8.
6. Martin JL, Laster MJ, Kandel L, et al. Metabolism of compound A by renal cysteine-S-conjugate β-lyase is not the mechanism of compound A-induced renal injury in the rat. Anesth Analg 1996;82:770-4.
7. Higuchi H, Sumita S, Wada H, et al. Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity. Anesthesiology 1998;88:307-22.
8. Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-8.
9. Berndt WO. Use of renal function tests in the evaluation of nephrotoxic effects. In: Hook JB, ed. Toxicology of the kidney. New York: Raven, 1981:1-29.
10. Frink Jr EJ, Ghantous HN, Malan TP, et al. Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function. Anesth Analg 1992;74:231-5.
11. Malan TP. Sevoflurane and renal function. Anesth Analg 1995; 81:539-45.
12. Charlson ME, MacKenzie CR, Gold JP, Shires T. Postoperative changes in serum creatinine: when do they occur and how much is important? Ann Surg 1989;209:328-33.
13. Abel RM, Buckley MJ, Austen WG, et al. Etiology, incidence and prognosis of renal failure following cardiac operations. J Thoracic Cardiovasc Surg 1976;71:323-33.
14. Novis BK, Roizen MF, Aronson S, Thisted RA. Association of preoperative risk factors with postoperative acute renal failure. Anesth Analg 1994;78:143-9.
15. Munday IT, Stoddart PA, Jones RM, et al. Serum fluoride concentration and urine osmolality after enflurane and sevoflurane anesthesia in male volunteers. Anesth Analg 1995;81:353-9.
16. Frink Jr EJ, Malan TP, Isner RJ, et al. Renal concentrating function with prolonged sevoflurane or enflurane anesthesia in volunteers. Anesthesiology 1994;80:1019-25.
17. Gonsowski C, Laster M, Eger E, et al. Toxicity of compound A in rats: effect of increasing duration of administration. Anesthesiology 1994;80:566-73.
18. Iyer RA, Baggs RB, Anders MW. Nephrotoxicity of the glutathione and cysteine s-conjugates of the sevoflurane degradation product 2-(fluoromethoxy)-1,1,3,3,3-pentafluoro-1-propene (compound) in male Fischer 344 rats. J Pharmacol Exp Ther 1997;283:1544-51.
19. Kharasch ED, Thorning D, Carton K, et al. Role of renal cysteine conjugate beta-lyase in the mechanism of compound A nephrotoxicity in rats. Anesthesiology 1997;86:160-71.
20. Dekant W, Vamvakas S, Anders MW. Formation and fate of nephrotoxic and cytoxic glutathione s-conjugates: cysteine conjugate B-lyase pathway. Adv Pharmacol 1994;27:115-62.
21. Iyer RA, Anders MW. Cysteine conjugate beta-lyase-dependent biotransformation of the cysteine s-conjugates of the sevoflurane degradation product compound A in human, nonhuman primate, and rat kidney cytosol and mitochondria. Anesthesiology 1996;85:1454-61.
22. Mazze RI, Friedman M, Delgado-Herrera L, et al. Renal toxicity of compound A plus sevoflurane in non-human primates [abstract]. Anesthesiology 1998;89:A490.
23. Keller KA, Callan C, Prokocimer P, et al. Inhalation toxicity study of a haloalkene degradant of sevoflurane, compound A (PIFE), in Sprague-Dawley rats. Anesthesiology 1995;83: 1220-32.
24. Bito H, Ideda K. Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents. Anesthesiology 1994; 81:340-5.
25. Ebert TJ, Frink Jr EJ, Kharasch ED. Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration of sevoflurane anesthesia in volunteers. Anesthesiology 1998;88:601-10.
26. Baines AD. Strategies and criteria for developing new urinalysis tests. Kidney Int 1994;46(Suppl 47):S137-41.
27. Obata R, Bito H, Goroku M, Sato S. The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function [abstract]. Anesthesiology 1999;91:A406.
28. Ebert TJ, Arain SR. Renal effects of low-flow anesthesia with desflurane and sevoflurane in patients [abstract]. Anesthesiology 1999;91:A404.
29. Goldberg ME, Cantillo J, Gratz I, et al. Doses of compound A, not sevoflurane, determines changes in the biochemical markers of renal injury in healthy volunteers. Anesth Analg 1999;88: 437-45.